SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,728.16 -281.09
( -0.36%)

Global Indices

Nasdaq

53,757.60 -103.39
(-0.19%)

Dow Jones

7,807.18 -12.81
(-0.16%)

Hang Seng

69,148.70 434.90
(0.63%)

Nikkei 225

10,727.81 -22.30
(-0.21%)

Forex

USD-INR

95.39 0.02
(0.02%)

EUR-INR

109.98 -0.03
(-0.03%)

GBP-INR

128.68 -0.13
(-0.10%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524824

INE083D01012

65.3864135

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALPHARMA

18.14

137.8

EPS(TTM)

Face Value()

Div & Yield %

4.77

1.39

Back

Empire Industries standalone net profit rises 0.57% in the December 2025 quarter

Feb 11,2026

Net profit of Empire Industries rose 0.57% to Rs 10.58 crore in the quarter ended December 2025 as against Rs 10.52 crore during the previous quarter ended December 2024. Sales rose 7.49% to Rs 188.64 crore in the quarter ended December 2025 as against Rs 175.50 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	188.64	175.50	7
OPM %	9.14	10.21	-
PBDT	16.05	15.63	3
PBT	11.98	11.52	4
NP	10.58	10.52	1

77,728.16 -281.09 ( -0.36%)

53,757.60 -103.39 (-0.19%)

7,807.18 -12.81 (-0.16%)

69,148.70 434.90 (0.63%)

10,727.81 -22.30 (-0.21%)

95.39 0.02 (0.02%)

109.98 -0.03 (-0.03%)

128.68 -0.13 (-0.10%)

0.60 0.00 (-0.03%)